Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AZN

Astrazeneca plc ADR

May 10 • 04:00PM ET

77.18

Dollar change -0.43
Percentage change -0.55	%

Healthcare • Drug Manufacturers - General • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX	P/E	38.04	EPS (ttm)	2.03	Insider Own	0.03%	Shs Outstand	3.10B	Perf Week	1.09%
Market Cap	239.30B	Forward P/E	16.46	EPS next Y	4.69	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	11.13%
Income	6.33B	PEG	2.82	EPS next Q	1.00	Inst Own	15.97%	Short Float	0.28%	Perf Quarter	23.96%
Sales	47.61B	P/S	5.03	EPS this Y	12.44%	Inst Trans	-2.09%	Short Ratio	1.42	Perf Half Y	21.49%
Book/sh	12.63	P/B	6.11	EPS next Y	14.87%	ROA	6.36%	Short Interest	8.53M	Perf Year	3.09%
Cash/sh	2.59	P/C	29.83	EPS next 5Y	13.50%	ROE	17.29%	52W Range	60.47 - 77.64	Perf YTD	14.60%
Dividend Est.	1.54 (2.00%)	P/FCF	28.22	EPS past 5Y	17.72%	ROI	9.64%	52W High	-0.59%	Beta	0.49
Dividend TTM	1.45 (1.88%)	Quick Ratio	0.70	Sales past 5Y	16.24%	Gross Margin	73.81%	52W Low	27.63%	ATR (14)	1.04
Dividend Ex-Date	Feb 22, 2024	Current Ratio	0.89	EPS Y/Y TTM	34.54%	Oper. Margin	17.50%	RSI (14)	75.69	Volatility	0.80% 1.14%
Employees	89900	Debt/Eq	0.92	Sales Y/Y TTM	8.60%	Profit Margin	13.30%	Recom	1.68	Target Price	81.85
Option/Short	Yes / Yes	LT Debt/Eq	0.75	EPS Q/Q	20.85%	Payout	73.87%	Rel Volume	0.60	Prev Close	77.61
Sales Surprise	7.47%	EPS Surprise	7.80%	Sales Q/Q	16.55%	Earnings	Apr 25 BMO	Avg Volume	6.01M	Price	77.18
SMA20	5.70%	SMA50	11.52%	SMA200	14.90%	Trades		Volume	3,606,029	Change	-0.55%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-29-22	Upgrade	Argus	Hold → Buy	$75
Jun-14-22	Downgrade	UBS	Buy → Neutral
Feb-11-22	Upgrade	DZ Bank	Sell → Hold
Dec-07-21	Downgrade	Jefferies	Buy → Hold
Aug-12-21	Resumed	JP Morgan	Overweight
Apr-12-21	Downgrade	Argus	Buy → Hold

Show Previous Ratings

May-10-24 09:45AM	Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term (Zacks)
09:30AM	Catalyst's New CEO Has Big Ideas For The Small Biotech (Investor's Business Daily)
06:30AM	3 Biotech Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
May-09-24 03:48PM	Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:31PM	Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:26AM	Loading…
10:26AM	Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb (PR Newswire)
May-08-24 04:28PM	Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents (MT Newswires)
04:08PM	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents (MT Newswires)
03:15PM	Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:07PM	AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement (MT Newswires)
01:30PM	AstraZenca is pulling its COVID vaccine (Quartz)
01:06PM	Every household should be forced to have a smart meter, says British Gas boss (The Telegraph)
11:47AM	AstraZeneca withdraws Covid-19 vaccine, citing low demand (CNN Business)
09:04AM	AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand (MT Newswires)
08:30AM	Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024 (GlobeNewswire)
08:12AM	Loading…
08:12AM	AstraZeneca withdraws COVID-19 vaccine, citing declining demand (BioPharma Dive)
06:02AM	AstraZeneca to withdraw Covid-19 vaccine globally (Pharmaceutical Technology)
06:00AM	7 Stocks to Buy Before the Next 'Great Reset' Begins in 2024 (InvestorPlace)
05:20AM	Q1 2024 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-07-24 11:12PM	PRESS DIGEST-British Business - May 8 (Reuters)
05:03PM	UPDATE 3-AstraZeneca to withdraw COVID vaccine globally as demand dips (Reuters)
10:15AM	FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:57AM	Q1 2024 FibroGen Inc Earnings Call (Thomson Reuters StreetEvents)
04:31AM	AstraZeneca concludes equity investment in Cellectis (Pharmaceutical Technology)
May-06-24 02:06PM	How the Medical Industry Could Produce the Biggest AI Stock Winners (InvestorPlace)
11:45AM	Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio (Zacks)
07:58AM	AstraZeneca ups stake in Cellectis in latest cell therapy bet (BioPharma Dive)
04:22AM	Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca (MT Newswires)
02:00AM	Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca (GlobeNewswire)
May-04-24 07:38AM	23 Most Profitable Stocks of the Last 12 Months (Insider Monkey)
12:15PM	Loading…
May-03-24 12:15PM	Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 (PR Newswire)
04:21AM	AstraZeneca reports positive interim data from mantle cell lymphoma trial (Clinical Trials Arena)
02:00AM	Angle PLC Announces New Commercial Agreement with Large Pharma (ACCESSWIRE)
May-02-24 03:29PM	Boston Properties, Inc. (NYSE:BXP) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:02AM	AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial (MT Newswires)
07:00AM	CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial (Business Wire)
May-01-24 12:02PM	AstraZeneca admits Covid-19 vaccine may cause blood clots in very rare cases (Pharmaceutical Technology)
07:05AM	AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio (Business Wire)
Apr-30-24 10:40AM	AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 04:38PM	AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown (Benzinga)
11:22AM	AstraZenecas Fasenra: Approval for asthma may initiate COPD approval (Pharmaceutical Technology)
10:56AM	AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed (MT Newswires)
10:26AM	AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement (MT Newswires)
07:10AM	AstraZeneca, Daiichi look to broaden Enhertu use again with new study data (BioPharma Dive)
07:00AM	ENHERTU (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow (Business Wire)
Apr-26-24 05:16AM	Analyst Report: AstraZeneca PLC (Morningstar Research)
Apr-25-24 08:28PM	Analyst Report: AstraZeneca PLC (Morningstar Research) +5.38%
04:01PM	AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge (Investor's Business Daily)
03:49PM	AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain' (Yahoo Finance)
01:51PM	Sector Update: Health Care Stocks Drop in Afternoon Trading (MT Newswires)
01:47PM	AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up (Zacks)
12:36PM	Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump (MT Newswires)
12:30PM	AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript (Motley Fool)
12:03PM	AstraZeneca Gets a Boost From Sales of Its Cancer Drugs (Investopedia)
11:34AM	AstraZeneca reinforcing supply chain amid global tensions: CEO (Yahoo Finance Video)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
11:03AM	AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance (Benzinga)
09:30AM	Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
09:20AM	20 Counties with the Highest Cancer Rates in the US (Insider Monkey)
09:01AM	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday (MT Newswires)
08:19AM	Sector Update: Health Care (MT Newswires)
08:00AM	AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
07:53AM	AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:31AM	AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags (Investor's Business Daily)
06:29AM	AstraZeneca Q1 Core Earnings, Revenue Increase -- Shares Jump Premarket (MT Newswires)
05:29AM	AstraZeneca Earnings, Sales Rise, Beat Forecasts (The Wall Street Journal)
05:09AM	Astrazeneca: Q1 Earnings Snapshot (Associated Press Finance)
03:25AM	AstraZeneca drops GOLDILOX and the porcupine in R&D update (FierceBiotech.com)
02:10AM	UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth (Reuters)
02:06AM	AstraZeneca leaps after smashing first-quarter forecasts (Reuters)
02:00AM	Q1 2024 results (Business Wire)
Apr-24-24 05:50PM	Alphabet, Microsoft, Southwest earnings: What to watch (Yahoo Finance Video)
Apr-23-24 09:58AM	AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect (Zacks)
09:37AM	AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder (MT Newswires)
Apr-22-24 09:16AM	Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics (Zacks)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
07:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-19-24 02:05PM	20 Countries with the Highest Cancer Survival Rates in the World (Insider Monkey)
Apr-18-24 11:45AM	Astrazeneca (AZN) Could Be a Great Choice (Zacks)
Apr-16-24 07:00AM	IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial (Business Wire)
Apr-15-24 05:51PM	3 Pharma Stocks That Are Money-Printing Machines in 2024 (InvestorPlace)
Apr-14-24 08:10PM	PRESS DIGEST- Financial Times - April 15 (Reuters)
04:41AM	4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market (Motley Fool)
Apr-13-24 12:18PM	Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024 (Insider Monkey)
09:00AM	Elon Musk's attack, Jamie Dimon's warnings, AstraZeneca CEO's big pay: Leadership news roundup (Quartz)
Apr-12-24 10:33AM	AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids (Zacks)
05:00AM	Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up (Quartz)
Apr-11-24 06:15PM	Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know (Zacks)
01:53PM	AstraZeneca hit by investor backlash over chief Pascal Soriots £19m pay deal (The Telegraph)
01:32PM	World risks tepid Twenties as debt levels and inflation soar, warns IMF (The Telegraph)
01:01PM	AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition (Reuters)
12:53PM	UPDATE 2-AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition (Reuters)
12:37PM	AstraZeneca shareholders approve 2024 pay policy at AGM (Reuters)
09:15AM	Biotech Innovations Paving the Way in Breast Cancer Fight (PR Newswire)
07:00AM	FASENRA approved for treatment of children aged 6 to 11 with severe asthma (Business Wire)
05:16AM	CORRECTED-UPDATE 1-European shares dip ahead of ECB policy decision (Reuters)
02:30AM	AstraZeneca announces dividend hike ahead of CEO pay vote (Reuters)
Apr-10-24 11:52AM	AstraZeneca's CEO makes double what Novo Nordisk's chief is paid. He needs a raise, some investors say (Quartz)
06:10AM	Major investors say AstraZeneca boss is massively underpaid on $21.5 million salary, despite earning more than double Novo Nordisks CEO (Fortune)
12:00AM	ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy? (TipRanks)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc ADR

Upgrade your FINVIZ experience